Kay-Gunnar Stubenrauch

This inventor holds 36 USPTO granted patents and 19 published patent applications, plus 13 CIPO patents and 30 EPO patents, primarily in Antibody Engineering. Top assignees: Hoffmann-La Roche Inc., Roche Glycart Ag, F. Hoffmann-La Roche Ag. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kay-Gunnar Stubenrauch. Retrieved from https://idiyas.com/inventor/kay-gunnar-stubenrauch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 36 (Patent Applications = 19)

% Patents Active = 94.4

CIPO Patents = 13 (Patent Applications = 9)

EPO Patents = 30 (Patent Applications = 30)

Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 252(Granted Patents)

Location History:

Munich, DE (2002)
Penzberg, CH (2010 - 2017)
Penzberg, DE (2009 - 2024)

Company Filing History:

31 out of 5,026

Hoffmann-La Roche Inc.

F. Hoffmann-La Roche Ag

5. 1 out of 834,513

Other

patents

Years Active: 2002-2025

Loading Chart...

Areas of Expertise:

Antibody

Immunoassay

Bispecific

Fc-region

Anti-drug

P-selectin

VEGF

ANG-2

Chimeric Polypeptides

Therapeutic Antibody

Nucleic Acids

Detection

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12291561 - Antigen binding receptors specific for mutated Fc domains (2025-05-06),

2. 11970550 - Anti-variant Fc-region antibodies and method of use (2024-04-30),

3. 11913945 - Method for determining the amount of a therapeutic antibody in the brain (2024-02-27),

4. 11679127 - Antigen binding receptors specific for mutated Fc domains (2023-06-20),

5. 11561229 - Immunoassay for the determination of Fc-region modified antibodies (2023-01-24),

6. 11340234 - Method for the determination of anti-drug antibodies against an effector function suppressed human or humanized drug antibody (2022-05-24),

7. 11313864 - Method for determining anti-drug antibodies in a minipig sample (2022-04-26),

8. 11242390 - Protease-activated T cell bispecific molecules (2022-02-08),

9. 10899845 - Anti-variant Fc-region antibodies and method of use (2021-01-26),

10. 10761097 - Method for the detection of a binding partner of a multispecific binder (2020-09-01),

11. 10761091 - Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples (2020-09-01),

12. 10683345 - Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases (2020-06-16),

13. 10502746 - Specific detection of rat antibodies in mouse serum (2019-12-10),

14. 10168326 - Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples (2019-01-01),

15. 9957331 - Non-cross-reactive anti IgG antibodies (2018-05-01),

Title: Kay-Gunnar Stubenrauch - Innovative Inventor from Penzberg

Introduction: Kay-Gunnar Stubenrauch is a renowned inventor hailing from Penzberg, Germany, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Kay-Gunnar Stubenrauch holds several patents in the areas of renewable energy, sustainable materials, and advanced manufacturing processes, showcasing his commitment to creating a more sustainable future.

Career Highlights: With over two decades of experience in the industry, Stubenrauch has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized the way we approach environmental challenges.

Collaborations: Throughout his career, Kay-Gunnar Stubenrauch has collaborated with top universities, research institutions, and multinational corporations to bring his innovative ideas to life, fostering a culture of creativity and collaboration in the field of technology.

Conclusion: Kay-Gunnar Stubenrauch's passion for innovation and his dedication to creating a positive impact on the world through his inventions make him a true pioneer in the field of technology.

Profile summary based on public USPTO records.